Brazil Overrides Merck Patent on Aids Drug (New York Times)

The government, whose spending on AIDS drugs has skyrocketed as more patients have needed costly, patented medicines, overrode the patent held by the pharmaceutical company Merck on the antiretroviral drug efavirenz. The cost of Merck?s drugs has been $580 annually per patient. Brazil said the company had offered a 30 percent discount, but the government opted instead to buy the generic version …

Read more detail on Legal News Directory – Intellectual Property

This entry was posted in Intellectual Property and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply